TRACEY GUILFOY: Open Payments
NPI 1487198966 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Amgen Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $32 |
| PFIZER INC. | 1 | $21 |
Products named: Rybelsus, MOUNJARO, FARXIGA, REPATHA, OTEZLA, PREVNAR 20, Ozempic.
Industry payments across VA — which companies pay providers there.
